ANXA2 and central nervous system cancer: Moreover the expression of anxa2 was thoroughly validated at the level of immunohistochemistry in additional tissue samples of GBM xenograft models as well as on large number of more than 200 clinical gliomas samples of various grades in a form of a tissue microarray as shown in our previous research.